Does L-arginine induce intestinal adaptation by epithelial growth factor?

Area of Science:

• Gastroenterology
• Surgical Research
• Nutritional Science

Background:

• Massive small bowel resection leads to intestinal insufficiency.
• Epidermal growth factor (EGF) plays a crucial role in intestinal healing and adaptation.
• L-Arginine is an amino acid with potential roles in wound healing and tissue regeneration.

Purpose of the Study:

• To investigate the effect of L-Arginine on endogenous EGF secretion.
• To evaluate the impact of L-Arginine on intestinal adaptation following massive small bowel resection.
• To determine if L-Arginine supplementation enhances recovery after significant bowel resection.

Main Methods:

• An experimental study involving 50% small bowel resection in Wistar rats.
• Rats were divided into L-Arginine treatment (500 mg/kg/day) and control (saline) groups for 14 days.
• Assessment included daily weight monitoring, serum/saliva/urine EGF levels (ELISA), and histopathological examination of the small bowel.

Main Results:

• L-Arginine treated rats showed significantly higher weight gain compared to controls (P < 0.05).
• Elevated serum, saliva, and urinary EGF levels were observed in the L-Arginine group (P < 0.05).
• Histopathological analysis revealed increased villus height in L-Arginine treated rats (P < 0.05).

Conclusions:

• L-Arginine supplementation promotes better intestinal adaptation after massive small bowel resection.
• Increased endogenous EGF levels in body fluids of L-Arginine treated rats may explain the observed benefits.
• L-Arginine shows promise as a therapeutic agent to improve outcomes in patients with short bowel syndrome.